1
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Currently, the value of using hyperbaric oxygen therapy in the treatment of mental illness has...

2
by Peprah, Kwakye, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for the use of Dialectical Behavioral Therapy (DBT) in the treatment of adult patients with mental illness...

3
by Peprah, Kwakye, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for the use of Dialectical Behavioral Therapy (DBT) in the treatment of adult patients with mental illness...

4
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Currently, the value of using hyperbaric oxygen therapy in the treatment of mental illness has...

5
by Jahagirdar, Deepa, Kaunelis, David
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Mentally Ill Persons...

6
by Jahagirdar, Deepa, Kaunelis, David
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Mentally Ill Persons...

7
by Ho, Chuong, Adcock, Lorna
Published 2017
Canadian Agency for Drugs and Technologies in Health
... of STPP for the treatment of these mental illnesses will also be examined...

8
by Ho, Chuong, Adcock, Lorna
Published 2017
Canadian Agency for Drugs and Technologies in Health
... of STPP for the treatment of these mental illnesses will also be examined...

9
Published 2019
CADTH
... with mild-to-moderate atopic dermatitis (AD). Crisaborole is a topical ointment that is recommended for use...

10
Published 2019
CADTH
... with mild-to-moderate atopic dermatitis (AD). Crisaborole is a topical ointment that is recommended for use...

17
by Yeung, Shirley S. T., Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Critical Illness...

18
by Banerjee, Srabani, Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Severity of Illness Index...

19
by Banerjee, Srabani, Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Severity of Illness Index...

20
by MacDonald, Erika, McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
... of ondansetron for pediatric patients with or at risk of mild to moderate dehydration. For the purposes...